Namodenoson is a highly selective A3 adenosine receptor (A3AR) agonist, which has shown a compelling safety profile and ...

One of the biggest risks for getting pancreatic cancer is smoking. Research shows that people who smoke are about twice as ...

Oral health's crucial role in systemic diseases, including cancer, underscores the need for improved surveillance and ...

Actuate Therapeutics' elraglusib shows promise in metastatic pancreatic cancer. Upcoming FDA meeting may accelerate approval.

Alcohol is an established risk factor for seven cancer types, but pancreatic cancer has not yet made the list. A recent analysis may change that.

Pancreatic cancer is among the deadliest cancers across the world, as it does not show initial symptoms and evades early ...

A group of scientists in Japan has discovered that fermented stevia may hold intriguing anti-cancer properties ...

Scientists at UC San Diego have found a gene pattern linked to stress and inflammation that may predict pancreatic cancer before it gets aggressive. The discovery centres on a gene called Integrin β3, ...

Pancreatic cancer is one of the deadliest types of cancer in the world. Only about 13 out of every 100 people diagnosed with ...

Sudden diabetes in adults could signal pancreatic cancer. Research indicates a link between new diabetes and this cancer.

It will be piloted in Cambridge on the PemOla trial, a precision medicine study exploring a combination immunotherapy, using ...

Cabometyx® is the first and only systemic therapy to be approved in the European Union for previously treated unresectable or ...